by Clinical Neuropsychologist Online | Tuesday, October 13, 2026 | Dementia
Abstract INTRODUCTION Metabolic dysregulation is a hallmark of Alzheimer’s disease (AD), with numerous studies characterizing metabolic pathways associated with AD onset and progression. A limitation of these studies has been a focus on non-Hispanic white...
by Clinical Neuropsychologist Online | Tuesday, October 13, 2026 | Dementia
Abstract INTRODUCTION Sex differences exist in Alzheimer’s disease (AD) treatment response, but the role of sex in disease development and progression remains unclear. METHODS We performed multimodal analyses of AD biomarker–positive individuals with mild...
by Clinical Neuropsychologist Online | Tuesday, October 13, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 10, October 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | October 13, 2026 Neuro-Dementia...
by Clinical Neuropsychologist Online | Tuesday, October 13, 2026 | Neuroscience
CNS 2027 Q&A In 2011, sociologist David Finkelhor coined the term “juvenoia” to describe an exaggerated fear older adults have about the impact of social change on children and youth. A combination of “juvenile” and “paranoia,” juvenoia seems to pop up in every...
by Clinical Neuropsychologist Online | Tuesday, October 13, 2026 | Dementia
Abstract INTRODUCTION Whether cognitive–social engagement can compensate for insufficient structured exercise in cognitive aging remains unclear. METHODS We harmonized repeated data from four aging cohorts across Asia, North America, and Europe. Structured exercise...
